课题基金 / 基金详情

Institutional Career Development Core

Institutional Career Development Core
机构职业发展核心
批准号:
10666364
负责人:
Faheem W Guirgis
金额:
$82.92万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-08-15 至 2025-06-30

项目摘要

项目成果

Faheem W Guirgis的其他基金

相似基金

相关文献

中文摘要
翻译
CTSI的辅导职业发展(KL2)计划的主要目标是教育和培训多样化的、 佛罗里达大学健康科学中心(UFHSC)多学科早期调查人员(ESI), 和几个附属机构在研究翻译中发挥领导作用。次要目标是参与 佛罗里达州立大学(FSU)的翻译劳动力发展领导力将建立正式的K 学者培训计划。这些目标将通过完成五个具体目标来实现。首先,一个灵活的, 为期两年的教学课程和指导研究将提供严格的核心学习 临床博士或博士从事成功的翻译研究事业所需的能力。 创新方面包括将KL2课程扩展到UF学院和校园的ESI,一个KL2预科课程 临床医生计划,修订的临床和转化健康科学证书,以及导师 学院扩展为一门在线课程,以发展指导技能。第二,在两年的培训期间, 一系列职业发展机会将培养沟通、指导、 研究管理、教学、协作/团队科学、领导力以及拨款撰写。创新型 内容包括将所有ESI组织成K学院,每月举行职业发展会议, 为R BootCamp编写他们的第一个R01应用程序,生物医学科学家证书计划为 教育工作者、职业兴趣团队和地区CTSA中心的KL2外部实习。第三,我们将招聘和 保留四名KL2学者(为期两年),他们在人口统计、专业、 和职业生涯规划。创新方面将从我们的K学院池中招聘(目前从10名ESI招聘143名 大学和几个校园,包括佛罗里达州立大学),以及我们的多样性和包容性工作项目 确保代表人数不足的群体的参与。第四,区域示范项目 将在UF校区、FSU和附属学术机构远程开发ESI 在密歇根大学校园里。创新方面包括转换所有课程、证书计划、补助金- 写作研讨会和研讨会,利用直播、视频存档和在线/远程学习机会 或不同步的在线学习课程。第五,该计划的影响将通过收购CORE进行评估 能力和学者职业发展轨迹。创新方面已经将核心能力映射到 所有KL2学者的课程和15年跟踪。到目前为止,所有23名KL2奖学金获得者都继续在 科学。在当前的资助期间,所有八名KL2奖学金毕业生将获得NIH的K或R基金,以及 出版物和演示文稿的高水平生产力。在下一个资助期结束时,九龙第二期 计划将继续在独立研究生涯中推出ESI,但随着 FSU和其他密歇根州立大学附属校区和项目的课程,从而为 翻译职业发展的区域化。
英文摘要
The primary goal of the CTSI’s Mentored Career Development (KL2) Program is to educate and train diverse, multidisciplinary Early Stage Investigators (ESI) at the University of Florida Health Science Center (UFHSC), and several affiliated institutions for leadership roles in research translation. A secondary goal is to engage Translational Workforce Development leadership at Florida State University (FSU) to establish a formal K Scholar Training Program. These goals will be attained by completion of five specific aims. First, a flexible, two-year curriculum of didactic courses and mentored research will provide for the rigorous learning of core competencies that clinical doctorates or PhD’s require to pursue successful translational research careers. Innovative aspects include extension of KL2 Programs to ESI’s across UF Colleges and campuses, a pre KL2 Program for clinicians, a revised Certificate in Clinical and Translational Health Science, and a Mentor Academy expanded to an online course to develop mentoring skills. Second, over the two-year training period, a series of career development opportunities will build professional skills in communication, mentoring, research management, teaching, collaboration/team science, leadership, as well as grant writing. Innovative components include the organization of all ESI’s into a K College with monthly career development sessions, K to R Bootcamp for writing their first R01 application, a Certificate Program in Biomedical Scientists as Educators, Career Interest Teams, and KL2 Externships with regional CTSA hubs. Third, we will recruit and retain four KL2 scholars (two-year appointments) who are diverse with regards to demographics, profession, and career plans. Innovative aspects will be recruitment from our K College pool (currently 143 ESI’s from 10 colleges and several campuses, including FSU), and programs from our Diversity and Inclusion Working Groups to assure participation from underrepresented groups. Fourth, a model program for regional development will be developed for ESI’s at UF campuses, FSU, and affiliated academic institutions distant from the UF campus. Innovative aspects include the conversion of all courses, Certificate Programs, grant- writing workshops, and seminars to online/distance learning opportunities using livestreaming, videoarchiving, or asynchronous online learning curricula. Fifth, the program’s impact will be assessed by acquisition of core competencies and scholar career trajectories. Innovative aspects have been mapping of core competencies to the curriculum and 15 year tracking of all KL2 scholars. To date, all 23 KL2 Scholars continue careers in science. In the current period of funding, all eight KL2 Scholar graduates will have K or R funds from NIH, with high levels of productivity in publications and presentations. At the end of the next period of funding, the KL2 Program will have continued to launch ESI’s onto independent research careers, but with expansions of programs to FSU and other UF affiliated campuses and programs, thereby creating a model program for regionalization of translational career development.
期刊论文(82)
专著(0)
科研奖励(0)
会议论文
Can the Healthy Start Risk Screen Predict Perinatal Depressive Symptoms among High-Risk Women?
健康的开始风险筛查可以预测高危女性的围产期抑郁症状吗?
DOI: 10.3390/children9020180
发表时间: 2022-02-01
期刊: Children (Basel, Switzerland)
影响因子: --
作者: [Wilson R, Campos A, Sandhu M, Sniffen S, Jones R, Tackett H, Berry E, Louis-Jacques A]
通讯作者: Louis-Jacques A
DOI: 10.1371/journal.pone.0153575
发表时间: 2016
期刊: PloS one
影响因子: 3.7
作者: [Séraphin MN, Lauzardo M, Doggett RT, Zabala J, Morris JG Jr, Blackburn JK]
通讯作者: Blackburn JK
Measures of impulsivity in Parkinson's disease decrease after DBS in the setting of stable dopamine therapy.
在稳定多巴胺治疗的情况下,DBS 治疗后帕金森病的冲动性指标有所下降。
DOI: 10.1016/j.parkreldis.2017.08.006
发表时间: 2017
期刊: Parkinsonism & related disorders
影响因子: 4.1
作者: [Rossi,PJustin, DeJesus,Sol, Hess,ChristopherW, Martinez-Ramirez,Daniel, Foote,KellyD, Gunduz,Aysegul, Okun,MichaelS]
通讯作者: Okun,MichaelS
DOI: 10.1186/s13054-016-1579-8
发表时间: 2016-12-23
期刊: Critical care (London, England)
影响因子: --
作者: [Guirgis FW, Donnelly JP, Dodani S, Howard G, Safford MM, Levitan EB, Wang HE]
通讯作者: Wang HE
50
    The Role and Mechanisms of Lipid and Lipoprotein Dysregulation in Sepsis
    • 批准号:
      10374081
    • 项目类别:
    • 资助金额:
      $48.55万
    • 财政年份:
      2020
    • 负责人:
      Faheem W Guirgis
    • 依托单位:
    The Role and Mechanisms of Lipid and Lipoprotein Dysregulation in Sepsis
    • 批准号:
      10382511
    • 项目类别:
    • 资助金额:
      $5.0万
    • 财政年份:
      2020
    • 负责人:
      Faheem W Guirgis
    • 依托单位:
    The Role and Mechanisms of Lipid and Lipoprotein Dysregulation in Sepsis
    • 批准号:
      10591486
    • 项目类别:
    • 资助金额:
      $47.33万
    • 财政年份:
      2020
    • 负责人:
      Faheem W Guirgis
    • 依托单位:
    The Role of Dysfunctional HDL in Sepsis
    • 批准号:
      9355200
    • 项目类别:
    • 资助金额:
      $18.06万
    • 财政年份:
      2016
    • 负责人:
      Faheem W Guirgis
    • 依托单位:
    海外基金